Bruce W. Boucher
Nessuna posizione attualmente
Profilo
Bruce W.
Boucher formerly worked at ClinTrials Research, Inc., as Senior Director-Finance, Cardinal Health, Inc., as Chief Financial Officer & General Manager, Liquidia Technologies, Inc., as President from 2004 to 2010, Pricewaterhouse LLP, as Principal, and Magellan Laboratories, Inc., as Chief Financial Officer & General Manager.
Precedenti posizioni note di Bruce W. Boucher
| Società | Posizione | Fine |
|---|---|---|
Magellan Laboratories, Inc.
 Magellan Laboratories, Inc. BiotechnologyHealth Technology Part of Cardinal Health, Inc., Magellan Laboratories, Inc. provides product development services of biological products. The company is based in Morrisville, NC. Magellan Laboratories was acquired by Cardinal Health, Inc. on March 18, 2002. | Direttore Finanziario/CFO | - |
| Pricewaterhouse LLP | Corporate Officer/Principal | - |
| CARDINAL HEALTH, INC. | Direttore Finanziario/CFO | - |
ClinTrials Research, Inc.
 ClinTrials Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Marvell Technology, Inc., ClinTrials Research, Inc. engages in clinical research organization. The company is based in Cary, NC. ClinTrials Research was acquired by Indigo Acquisition Corp on April 03, 2001 for $110.42 million. | Direttore Finanziario/CFO | - |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Direttore Finanziario/CFO | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CARDINAL HEALTH, INC. | Distribution Services |
| Aziende private | 4 |
|---|---|
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
ClinTrials Research, Inc.
ClinTrials Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Marvell Technology, Inc., ClinTrials Research, Inc. engages in clinical research organization. The company is based in Cary, NC. ClinTrials Research was acquired by Indigo Acquisition Corp on April 03, 2001 for $110.42 million. | Commercial Services |
| Pricewaterhouse LLP | Commercial Services |
Magellan Laboratories, Inc.
Magellan Laboratories, Inc. BiotechnologyHealth Technology Part of Cardinal Health, Inc., Magellan Laboratories, Inc. provides product development services of biological products. The company is based in Morrisville, NC. Magellan Laboratories was acquired by Cardinal Health, Inc. on March 18, 2002. | Health Technology |
- Borsa valori
- Insiders
- Bruce W. Boucher
